AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 66 filers reported holding AVROBIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $976,000 | – | 60,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,417,204 | $28,528,000 | 17.28% |
| Aisling Capital Management LP | 893,079 | $17,978,000 | 6.89% |
| AlpInvest Partners B.V. | 200,732 | $4,041,000 | 3.44% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $20,130,000 | 2.40% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $6,352,000 | 1.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,164,970 | $23,451,000 | 0.75% |
| Eventide Asset Management | 1,305,307 | $26,276,000 | 0.74% |
| Camber Capital Management LP | 600,000 | $12,078,000 | 0.62% |
| EMERALD ADVISERS, LLC | 656,306 | $13,211,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 641,387 | $12,911,000 | 0.53% |